Questions with no answer at all. Not questions with no accepted answer — those are elsewhere.
For reference: tirzepatide · 37 °C · fourteen days. I am at the decision point and I would rather think it through than improvise. I would rather spend money on…
This is a United States plan; I appreciate the answer is jurisdiction-specific. I have read the primary source rather than the summary, which has left me with more…
This is a recurring problem with one particular shipping lane rather than a one-off. Everything I have found on this is either a forum aside or a product page,…
Numbers first: injection-site erythema · dulaglutide. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like to…
Concretely: nine · 900 kcal. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the plan to…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I want to know whether this is a real physical effect or…
Concretely: survodutide · 5 mg/mL · ten weeks. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one.…
For reference: REDEFINE-1 · semaglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
For reference: 4 mg · 6.67 mg/mL. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor of…
For reference: TRIUMPH-3 · ecnoglutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The specifics, since they change the answer: GL Biochem · Chinese Peptide Company. The comparison I want does not seem to exist anywhere in a form I can evaluate. I…
Setup, so nobody has to ask: a 25G drawing needle · 5 mg/mL. I have worked this out and I would like someone to find the error, because I suspect there is one. My…
What I have: eGFR · orforglipron. I would rather over-plan the first cycle and simplify later. I am prepared to do the work if someone can tell me which work matters.…
Numbers first: a GLP-1 receptor agonist · a C8 column · survodutide. I have used one of these for a while and I am considering switching, which requires a reason.…
The case in front of me: hair thinning · tirzepatide · SURMOUNT-3. The figures are clear enough; the question is what they mean and what they do not. I can supply the…
What I am working with: Medutest · SWB. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do…
Setup, so nobody has to ask: constipation · mazdutide · STEP 2. I have read the primary source rather than the summary, which has left me with more questions. I…
What I have: STEP 3 · 40 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s interpretation…
For reference: two weeks · survodutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned…
What I am working with: SOUL · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
What I am working with: dulaglutide · ESSENCE. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
Details up front: cagrilintide · sixteen weeks · 37 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
The method section is present, which is unusual enough that I want to make use of it. I am trying to build something sustainable rather than something thorough that I…
Stated plainly: STEP 1 · dizziness · 40 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline.…